A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma

[1]  Hongtuan Zhang,et al.  Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma , 2022, Frontiers in Genetics.

[2]  Yong Zhang,et al.  Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma , 2022, Frontiers in Genetics.

[3]  Xianglin Yuan,et al.  Analysis of Ferroptosis-Related LncRNAs Signatures Associated with Tumor Immune Infiltration and Experimental Validation in Clear Cell Renal Cell Carcinoma , 2022, International journal of general medicine.

[4]  Hui Cao,et al.  A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients , 2021, Frontiers in Cell and Developmental Biology.

[5]  Y. Xun,et al.  Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma , 2021, Disease markers.

[6]  Min Gao,et al.  An autophagy-related lncRNA prognostic risk model for thyroid cancer , 2021, European Archives of Oto-Rhino-Laryngology.

[7]  Wei Ma,et al.  Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma , 2021, Bioscience reports.

[8]  Han Zheng,et al.  LncRNA LINC00944 Promotes Tumorigenesis but Suppresses Akt Phosphorylation in Renal Cell Carcinoma , 2021, Frontiers in Molecular Biosciences.

[9]  Hang Tong,et al.  A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma , 2021, Frontiers in Oncology.

[10]  Q. Hu,et al.  Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma , 2021, Frontiers in Oncology.

[11]  Yu Zhang,et al.  Ferroptosis‐related gene CHAC1 is a valid indicator for the poor prognosis of kidney renal clear cell carcinoma , 2021, Journal of cellular and molecular medicine.

[12]  Shijie Tang,et al.  Elevated LINC01550 induces the apoptosis and cell cycle arrest of melanoma , 2021, Medical Oncology.

[13]  Sen Li,et al.  An epithelial-mesenchymal transition-related long non-coding RNA signature to predict overall survival and immune microenvironment in kidney renal clear cell carcinoma , 2021, Bioengineered.

[14]  O. Harismendy,et al.  Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis. , 2020, Life sciences.

[15]  C. Qin,et al.  Upregulation of KIF20A promotes tumor proliferation and invasion in renal clear cell carcinoma and is associated with adverse clinical outcome , 2020, Aging.

[16]  R. Xu,et al.  LncRNA‐mediated posttranslational modifications and reprogramming of energy metabolism in cancer , 2020, Cancer communications.

[17]  Jiancheng Hu,et al.  The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy , 2020, Journal of Hematology & Oncology.

[18]  Ashton C. Berger,et al.  Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma , 2020, Nature Medicine.

[19]  A. Mohammed,et al.  Epidemiology of Renal Cell Carcinoma , 2020, World journal of oncology.

[20]  D. Lin,et al.  Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming , 2020, Nature Communications.

[21]  Xia Li,et al.  Pan-cancer characterization of immune-related lncRNAs identifies potential oncogenic biomarkers , 2020, Nature Communications.

[22]  M. Guan,et al.  Identification of Long Non-Coding RNA Expression Profiles and Co-Expression Genes in Thyroid Carcinoma Based on The Cancer Genome Atlas (TCGA) Database , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[23]  Yun Wang,et al.  LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer , 2019, Molecular Cancer.

[24]  A. Hakimi,et al.  Tumor Microenvironment Dynamics in Clear-Cell Renal Cell Carcinoma. , 2019, Cancer discovery.

[25]  M. Morgan,et al.  Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer. , 2019, The New England journal of medicine.

[26]  Yi Xiao,et al.  Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies , 2019, International Journal of Molecular Sciences.

[27]  Alireza Hadj Khodabakhshi,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[28]  C. Ahn,et al.  AICAR, an AMPK activator, protects against cisplatin-induced acute kidney injury through the JAK/STAT/SOCS pathway. , 2019, Biochemical and biophysical research communications.

[29]  A. Gavin,et al.  Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. , 2018, European journal of cancer.

[30]  W. Symmans,et al.  Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. , 2018, The Lancet. Oncology.

[31]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[32]  R. Brandes,et al.  Redox Regulation and Noncoding RNAs. , 2017, Antioxidants & redox signaling.

[33]  A. Jemal,et al.  Cancer statistics, 2018 , 2018, CA: a cancer journal for clinicians.

[34]  Subbroto Kumar Saha,et al.  Correlation between Oxidative Stress, Nutrition, and Cancer Initiation , 2017, International journal of molecular sciences.

[35]  Erin Hines,et al.  Exposure to Perfluorinated Alkyl Substances and Health Outcomes in Children: A Systematic Review of the Epidemiologic Literature , 2017, International journal of environmental research and public health.

[36]  G. Saed,et al.  Updates of the role of oxidative stress in the pathogenesis of ovarian cancer. , 2017, Gynecologic oncology.

[37]  Y. Mo,et al.  LncRNA-mediated regulation of cell signaling in cancer , 2017, Oncogene.

[38]  X. Shu,et al.  The Role of Biomarkers of Oxidative Stress in Breast Cancer Risk and Prognosis: A Systematic Review of the Epidemiologic Literature. , 2017, Journal of women's health.

[39]  J. Ioannidis,et al.  Long noncoding RNAs as novel predictors of survival in human cancer: a systematic review and meta-analysis , 2016, Molecular Cancer.

[40]  B. Oh,et al.  Oxidative stress in prostate cancer patients: A systematic review of case control studies , 2016, Prostate international.

[41]  Chris Sander,et al.  An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma. , 2016, Cancer cell.

[42]  Shiyong Wu,et al.  Reactive oxygen species in redox cancer therapy. , 2015, Cancer letters.

[43]  J. Lam,et al.  Surveillance strategies for renal cell carcinoma patients following nephrectomy. , 2006, Reviews in urology.

[44]  M. Birchall,et al.  A systematic review of case-control studies of human papillomavirus infection in laryngeal squamous cell carcinoma. , 2004, Clinical otolaryngology and allied sciences.

[45]  L. Neckers,et al.  IL‐1β mediated up‐regulation of HIF‐lα via an NFkB/COX‐2 pathway identifies HIF‐1 as a critical link between inflammation and oncogenesis , 2003 .

[46]  Yun-Jin Jung,et al.  IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  M. Brennan,et al.  Memorial Sloan-Kettering Cancer Center experience , 1997 .